肝癌介入治疗用于原发性肝癌中晚期患者的效果分析

Effect of Interventional Therapy for Hepatocellular Carcinoma in Patients with Middle and Late Stage of Primary Hepatocellular Carcinoma

目的:探讨肝癌介入治疗用于原发性肝癌中晚期患者的效果。方法:选择2014年3月-2016年6月84例原发性肝癌中晚期患者,进行随机分组。常规化疗组选择常规方式治疗,肝癌介入组选择肝癌介入治疗。分析两组的疗效、住院平均时间、病灶缩小50%时间、治疗前后肝功能相关指标及生存质量、并发症情况。结果:肝癌介入组肝功能相关指标、生存质量评分、住院平均时间、病灶缩小50%时间、并发症发生率及疗效均优于常规化疗组(P<0.05)。结论:原发性肝癌中晚期患者实施肝癌介入治疗可获得较好效果,可有效改善患者的肝功能,提升其生存质量,缩短住院时间,且并发症少,值得推广。

Objective:To investigate the efficacy of interventional therapy for hepatocellular carcinoma in patients with middle and late stage of primary hepatocellular carcinoma.Method:84 patients with middle and late stage of primary hepatocellular carcinoma from March 2014 to June 2016 were randomly divided into two groups.The routine chemotherapy group was chosen as routine treatment method,and the interventional therapy group was selected as interventional therapy for hepatocellular carcinoma.The curative effect,average hospitalization time,50% reduction time of focus,liver function related indexes and quality of life of patients before and after treatment,and complications were analyzed.Result:The liver function related indexes,quality of life,average hospitalization time,50% reduction time of focus,complications and curative effect were better than those of the routine chemotherapy group(P<0.05).Conclusion:Interventional therapy for middle and late stage of primary hepatocellular carcinoma can achieve better effects,improve liver function and quality of life,shorten hospitalization time,and have fewer complications,which is worthy of promotion.